GLP-1 weight management assessment (Wegovy, Saxenda, Mounjaro) in Seoul
GLP-1-related injections are prescription medicines considered for weight management after an obesity and medical-history assessment. The travel estimate is 1 night for an initial assessment and pickup if prescribed; continued monitoring is separate.
- Pain
- Typical recovery
- Same day
- Shortest stay
- 1 night
- Stay until marks settle
- 1 night
- Visits
- More than one visit
- Price example
- None found yet
Prescription medicine
This uses a medicine that is prescription-only in Korea. A doctor decides whether it is used and how much. Rules in Korea
Draft, not yet reviewed by a doctor
We wrote this from the sources listed at the end of the page. A doctor has not checked it yet.
What it is
GLP-1-related injections are prescription treatments considered after an obesity and medical-history assessment. They require ongoing monitoring rather than a one-off weight-loss visit, and eligibility differs by medicine and country.
Often used for
- A medical assessment of obesity and related health risks
- People able to coordinate ongoing prescribing and monitoring at home
Think twice if
- A quick cosmetic weight change during a short trip
- Pregnancy or intended weight loss during pregnancy
- A personal or family history of medullary thyroid carcinoma or MEN2 for products carrying that contraindication
- An unverified online or cosmetic-menu injection
How it works
Liraglutide and semaglutide activate the GLP-1 receptor, affecting appetite and glucose regulation. Tirzepatide acts at both GIP and GLP-1 receptors, so it is not an identical medicine.
- When results show
- After a few months
- How long results last
- Weight response and maintenance depend on continued medical management; no result duration is promised.
What happens on the day
- In-person eligibility assessment and medicine review
- If prescribed in clinic, verify delivery with a supervised first injection and pen education
- Arrange ongoing dose and injection-site review rather than a one-off cosmetic visit
What it feels like
The estimate covers assessment and dispensing, not the discomfort of a supervised starting dose. It does not score symptoms from the condition or adverse effects of medication.
Numbing: No routine anesthetic for the prescribing visit.
Recovery
Most people can go out in public the same day.
| When | What to expect |
|---|---|
| Same day | Consultation and dispensing leave no marks; a supervised first injection can leave a small needle dot. |
| Next day | If a dose was given, a small spot or mild redness can remain. |
| Day 3 | A routine starting-dose site is usually inconspicuous; persistent or increasing redness deserves follow-up. |
| After a week | There is no expected mark from the prescription visit; later doses can leave temporary spots of their own. |
| Makeup | No facial makeup restriction from the prescribing visit. |
Risks and side effects
Common reactions
- Nausea, vomiting, diarrhea or constipation
- Abdominal discomfort and injection-site reactions
Less common risks
- Pancreatitis
- Dehydration-related kidney problems
- Hypoglycemia, particularly with insulin or certain diabetes medicines
- Severe allergy; product-specific thyroid tumor warning
Contact the clinic right away if
- Persistent severe abdominal pain, especially radiating to the back, requires urgent assessment.
- Seek urgent care for repeated vomiting with inability to drink, fainting, confusion or severe allergic symptoms.
Safety checks before you book
- Usually not done if you are pregnant. Not a treatment for weight loss during pregnancy.
- Tell the doctor first if you are breastfeeding. Review the exact medicine and current labeling.
- Usually not done if you are allergic to an ingredient or anesthetic used. Prior serious allergy to the chosen medicine requires exclusion.
Tell the clinic about any medical conditions, medicines and recent treatments. A doctor at the clinic decides whether it suits you.
Fitting it into your trip
- Best day in your trip
- Arrange assessment early enough to discuss results and follow-up before departure.
- Flying home
- No procedure-related flight waiting period applies to the prescribing visit; ask about any medicine-specific or symptom-related concerns.
- Shortest stay
- 1 night from treatment day to departure
- Stay until marks settle
- 1 night
- After you fly home
- Korean Medical Association guidance describes review every four weeks for in-clinic dispensing. Confirm the first review with the prescriber and arrange care at home if it cannot be completed in Korea.
Allow 1 night for the initial assessment and prescription pickup, if prescribed. Arrange local prescribing and refills, check whether the product is available at home, and confirm storage and transport requirements before departure.
Sessions
The 2025 Korean Medical Association guidance describes a supervised initial administration for in-clinic dispensing and review every four weeks. Injection frequency depends on the prescribed product.
Plan GLP-1-related prescription injections for weight management around your dates
Rules in Korea
- These are prescription-only medicine in Korea. Brand names identify distinct formulations, not a recommendation.
- The master records Saxenda, Wegovy and Mounjaro Korean authorization; current Korean obesity indications, eligibility and visitor prescribing requirements need confirmation. U.S. labeling is cited for risks, not Korean eligibility.
Price
- How it is priced
- 펜, 회, 월
What changes the price
- Exact treatment and extent
- Consultation, testing and medication
- Interpreter support and follow-up
We have not found a published price for this yet. Ask for a written total with VAT before you agree.
No clinic-confirmed prices are published for GLP-1-related prescription injections for weight management yet. We publish them once 3 clinics have confirmed a total within 180 days.
Check it is genuine
- Use a licensed prescriber and pharmacy; verify sealed packaging, strength, lot, expiry and storage.
- Obtain a prescription record and check destination-country import and storage requirements.
| Name in Korea | Maker | Korean approval record | How it differs |
|---|---|---|---|
| Saxenda | Novo Nordisk | Found in the Korean MFDS product database (brand level) | Liraglutide; distinct from semaglutide. |
| Wegovy | Novo Nordisk | Found in the Korean MFDS product database (brand level) | Semaglutide; check the exact injectable formulation and strength, not oral products. |
| Mounjaro | Eli Lilly | Found in the Korean MFDS product database (brand level) | Tirzepatide, a dual GIP/GLP-1 receptor agonist; U.S. indications do not establish Korean indications. |
Questions to ask the clinic
- Which prescription-only medicine and pen strength is being assessed, without assuming eligibility?
- Who checks my health history and teaches the exact pen technique?
- What follow-up is available for vomiting or inability to keep fluids down?
- Does the total include examination, any tests, medicine and VAT where applicable?
- Can I obtain storage instructions and travel paperwork for my destination?
Frequently asked questions
Can a visitor get Wegovy, Saxenda, or Mounjaro in Korea?
These are prescription medicines. Visitor requirements and product-specific eligibility were not verified, so a Korean prescriber would need to assess whether any product is appropriate.
How often are GLP-1 prescriptions reviewed in Korea?
Korean medical guidance describes review every four weeks for in-clinic dispensing. That is distinct from injection frequency, which depends on the prescribed product.
How is a GLP-1 prescription priced in Seoul?
Quotes may be per pen, visit, or month. Consultation, testing, and follow-up can affect the total; a pharmacy price was not verified.
Clinics
No clinic has confirmed this treatment with us yet
Registered clinics are listed by area. We have not checked which of them offer GLP-1-related prescription injections for weight management, so ask the clinic before you go.
How we estimate
Pain, recovery days and the shortest stay are typical values for planning a trip, not a measurement for you. Each value says where it comes from: a cited source, Korean clinic aftercare guidance, what is typical for the method and anesthesia, or a similar treatment when no source gave a number.
- Pain: 1 of 5
- Typical for this method and anesthesia. The estimate covers assessment and dispensing, not the discomfort of a supervised starting dose. It does not score symptoms from the condition or adverse effects of medication.
- Typical recovery: Same day
- From a cited source. The Korean Medical Association guidance describes prescribing and dispensing, which do not cause visible procedural downtime. A supervised injection is a separate step.
- Shortest stay: 1 night
- Site rule: the later of 1 night, the last visit you need before flying, and the flight advice after the anesthesia used. A: The initial supervised administration described for in-clinic dispensing is generally part of the first visit. The four-week review is ongoing care, not assumed to require staying in Korea; confirm whether local follow-up is possible. B: A consultation without general anesthesia adds no anesthesia-related flight wait. C: One-night baseline for 0 days of visible downtime.
The pain scale
- 1: barely uncomfortable, no numbing
- 2: stinging or heat, numbing cream optional
- 3: numbing cream usually needed
- 4: hurts even with numbing cream; some choose sedation or a nerve block
- 5: surgery under sedation or general anesthesia
Sources and review
- Content status
- Draft, not yet reviewed by a doctor.
- Medical review
- Not reviewed yet
Sources
- Liraglutide safety information. Novo Nordisk, manufacturer, checked 18 Nov 2026
- Tirzepatide safety information; U.S. label. Eli Lilly, manufacturer, checked 18 Nov 2026
- Wegovy product search. MFDS, government, checked 18 Nov 2026
- Korean Medical Association guidance via KALDAT Korean patient information. Korean Medical Association guidance via KALDAT, medical society, checked 18 Nov 2026